0000000000596321

AUTHOR

Pablo Perez-martinez

showing 12 related works from this author

Safety Evaluation of α-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Studies

2020

Alpha-lipoic acid (ALA) is a natural short-chain fatty acid that has attracted great attention in recent years as an antioxidant molecule. However, some concerns have been recently raised regarding its safety profile. To address the issue, we aimed to assess ALA safety profile through a systematic review of the literature and a meta-analysis of the available randomized placebo-controlled clinical studies. The literature search included EMBASE, PubMed Medline, SCOPUS, Google Scholar, and ISI Web of Science by Clarivate databases up to 15th August 2020. Data were pooled from 71 clinical studies, comprising 155 treatment arms, which included 4749 subjects with 2558 subjects treated with ALA an…

:Chemicals and Drugs::Pharmaceutical Preparations::Placebos [Medical Subject Headings]Physiologyα -lipoic acid ; thioctic acid ; dietary supplement ; safety ; meta-analysisClinical BiochemistryDisease030204 cardiovascular system & hematologyBiochemistrymeta-analysi:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antioxidants [Medical Subject Headings]Dietary supplementchemistry.chemical_compound0302 clinical medicinethioctic aciddietary supplement meta-analysis safety thioctic acid α-lipoic acid:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Evaluation Studies as Topic::Clinical Trials as Topic::Controlled Clinical Trials as Topic::Randomized Controlled Trials as Topic [Medical Subject Headings]α-lipoic acidLipoic acidSafety profile:Publication Type::Study Characteristics::Meta-Analysis [Medical Subject Headings]Suplementos dietéticosMeta-analysis:Technology and Food and Beverages::Food and Beverages::Food::Dietary Supplements [Medical Subject Headings]SafetysafetyAlpha-lipoic acidmedicine.medical_specialtyMEDLINEÁcido tióctico030209 endocrinology & metabolismPlacebo:Chemicals and Drugs::Organic Chemicals::Sulfur Compounds::Thiophenes::Thioctic Acid [Medical Subject Headings]Article:Health Care::Environment and Public Health::Public Health::Accidents::Accident Prevention::Safety [Medical Subject Headings]03 medical and health sciencesα‐lipoic acidThioctic acidInternal medicineDiabetes mellitusmedicineMetaanálisisAdverse effectSeguridad:Diseases::Cardiovascular Diseases [Medical Subject Headings]Molecular Biology:Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids Volatile [Medical Subject Headings]business.industryRevisión sistemáticalcsh:RM1-950Cell Biologymedicine.disease:Psychiatry and Psychology::Behavior and Behavior Mechanisms::Behavior::Habits::Food Habits::Smoking [Medical Subject Headings]meta-analysisMeta-analysislcsh:Therapeutics. Pharmacologychemistry:Diseases::Nervous System Diseases [Medical Subject Headings]dietary supplementMeta‐analysisbusinessAntioxidants
researchProduct

LDL and HDL subfractions, dysfunctional HDL: treatment options.

2014

Low-density lipoproteins (LDL) are considered as important risk factors for cardiovascular diseases (CVD), while highdensity lipoproteins (HDL) are well recognized for their putative role in reverse cholesterol transport and other atheroprotective functions. Both LDL and HDL are heterogeneous in nature, including various subfractions depending on the method of isolation (≥ 7 LDL and 10 HDL subspecies, respectively). While it is established that small, dense LDL (sdLDL) have atherogenic potential, the role of different HDL subfractions is still largely unclear. The majority of clinical studies suggest an atheroprotective role of larger HDL particles, although recent work has highlighted the…

Drugmedicine.medical_specialtymedia_common.quotation_subjectDysfunctional familychemistry.chemical_compoundRisk FactorsInternal medicineDrug DiscoveryCholesterylester transfer proteinmedicineHumansmedia_commonPharmacologybiologybusiness.industryCholesterolReverse cholesterol transportnutritional and metabolic diseasesLipoproteins LDLResidual riskEndocrinologychemistryCardiovascular Diseasesbiology.proteinlipids (amino acids peptides and proteins)Hdl subfractionsHydroxymethylglutaryl-CoA Reductase InhibitorsLipoproteins HDLbusinessNiacin
researchProduct

Effects of Aging and Diet on Cardioprotection and Cardiometabolic Risk Markers.

2019

The prevalence of several diseases increases by age, including cardiovascular diseases, which are the leading cause of morbidity and mortality worldwide. Aging, as a complex process characterized by senescence, triggers various pathways, such as oxidative stress, systemic inflammation, metabolism dysfunction, telomere shortening, mitochondrial dysfunction and deregulated autophagy. A better understanding of the mechanisms underlying senescence may lead to the development of new therapeutic targets and strategies for age-related pathologies and extend the healthy lifespan. Modulating lifestyle risk factors and adopting healthy dietary patterns remain significant tools in delaying the aging …

SenescenceAgingmedia_common.quotation_subjectCardioprotectionDisease030204 cardiovascular system & hematologyDiabeteBioinformaticsSystemic inflammation03 medical and health sciences0302 clinical medicineRisk FactorsCardiovascular DiseaseDiabetes mellitusDrug DiscoveryMedicineHumansLife Style030304 developmental biologymedia_commonPharmacologyCardioprotection0303 health sciencesbusiness.industryRisk FactorLongevityCardiovascular riskmedicine.diseaseMetabolic syndromeDietCardiovascular DiseasesLife expectancyQuality of LifeNutraceuticalMetabolic syndromemedicine.symptombusinessHumanCurrent pharmaceutical design
researchProduct

COSMIC project : consensus on the objectives of the metabolic syndrome in clinic

2018

Juan Pedro-Botet,1 Juan F Ascaso,2,3 Vivencio Barrios,4,5 Alejandro De la Sierra,6 Javier Escalada,7,8 Jesús Millán,9 Jose M Mostaza,10 Pablo Pérez-Martínez,8,11 Xavier Pintó,8,12 Jordi Salas-Salvadó,8,13 Pedro Valdivielso14 1Lipids and Vascular Risk Unit, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain; 2Endocrinology and Nutrition Service, Hospital Clínico, Universitat de Valencia, Valencia, Spain; 3INCLIVA Research Institute, Diabetes and Metabolic Diseases Ciber (Networked Biomedical Research Centres – CIBERDEM), Carlos III, Valencia, Spain; 4Cardiology Service, Hospital Universitario Ramón y Caja…

medicine.medical_specialtydiabetes preventionSpecialties of internal medicineReviewDiseaseType 2 diabetes030204 cardiovascular system & hematologymetabolic syndromeScientific evidence03 medical and health sciences0302 clinical medicineDiabetes mellitusinsulin resistanceInternal MedicinemedicineCor -- Malalties -- Prevenció030212 general & internal medicineObesityRisk factorDiabetes preventionIntensive care medicineAbdominal obesityobesity.Pharmacologybusiness.industrycardiovascular preventionInsulin resistancemedicine.diseaseDiabetis -- PrevencióCardiovascular preventionRC581-951DyslipidemiaHypertensionObesitatHipertensióMetabolic syndromemedicine.symptombusinessDyslipidemia
researchProduct

Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation.

2017

The importance of metabolic syndrome (MetS) lies in its associated risk of cardiovascular disease and type 2 diabetes, as well as other harmful conditions such as nonalcoholic fatty liver disease. In this report, the available scientific evidence on the associations between lifestyle changes and MetS and its components is reviewed to derive recommendations for MetS prevention and management. Weight loss through an energy-restricted diet together with increased energy expenditure through physical activity contribute to the prevention and treatment of MetS. A Mediterranean-type diet, with or without energy restriction, is an effective treatment component. This dietary pattern should be built …

Estils de vidamedicine.medical_specialtylifestyleSíndrome metabòlica -- PrevencióMedicine (miscellaneous)Dietary pattern030209 endocrinology & metabolismDiseaseType 2 diabetes030204 cardiovascular system & hematologypanel recommendationWhole grains03 medical and health scienceschemistry.chemical_compound0302 clinical medicineWeight lossEnvironmental healthCardiovascular DiseaseNonalcoholic fatty liver diseasemedicineHumansLife StyleMetabolic SyndromeNutrition and Dieteticsbusiness.industryFeature ArticleUnsaturated fatPanel recommendationDietary patternmedicine.diseaseLifestyleDietchemistryDiabetes Mellitus Type 2Cardiovascular DiseasesPhysical therapydietary patternMetabolic syndromemedicine.symptombusinessHuman
researchProduct

Gut microbiota and aging-A focus on centenarians.

2020

Gut microbiota (GM) is a dynamic organ throughout the lifespan. Aging is a complex process that comprises a plethora of mechanisms such as senescence, immunosenescence and inflammaging, representing important pathways of age-related diseases. GM structure could both influence and be influenced by aging occurring changes within the host. A unique category of long living individuals exists, namely centenarians that have the outstanding capacity to adapt to various challenges. Longevity seems to be associated with certain GM which, among other factors, might render individuals more resistant to age-related diseases and subsequently to long living. Diet, prebiotics, probiotics and synbiotics ma…

0301 basic medicineSenescenceAgingSynbioticsmedia_common.quotation_subjectLongevitySynbioticsGut microbiotaBiologyGut flora03 medical and health sciences0302 clinical medicineCentenariansHumansAging Centenarians Gut microbiota Prebiotics Probiotics Synbiotics Aged 80 and over Aging Gastrointestinal Microbiome Humans Longevity Prebiotics Probiotics SynbioticsMolecular Biologymedia_commonAged 80 and overProbioticsLongevityImmunosenescencebiology.organism_classificationGastrointestinal Microbiome030104 developmental biologyPrebioticsImmunologyMolecular Medicine030217 neurology & neurosurgery
researchProduct

Nutraceuticals Supporting Body Weight Loss

2021

It is known that obesity has reached epidemic proportions and its management is of high clinical importance. In this chapter we will discuss recent data about the role of nutraceuticals and functional foods in obesity and body weight management, including the mechanisms responsible for their favorable effects. In addition, the impact of healthy dietary patterns on weight loss will be addressed. Apart from influencing the imbalance between energy intake and output, nutraceuticals may prevent and/or decrease the development of oxidative stress and inflammation in obesity, as well as favorably influence other cardiovascular disease risk factors, thereby limiting obesity-related complications. …

Clinical PracticeNutraceuticalbusiness.industryWeight lossEnvironmental healthDisease riskMedicineLimitingmedicine.symptombusinessmedicine.diseaseBody weightObesity
researchProduct

Gut Microbiota, Obesity and Bariatric Surgery: Current Knowledge and Future Perspectives.

2019

Background::There is an urgent need for a better understanding and management of obesity and obesity- associated diseases. It is known that obesity is associated with structural and functional changes in the microbiome.Methods::The purpose of this review is to present current evidence from animal and human studies, demonstrating the effects and the potential efficacy of microbiota modulation in improving obesity and associated metabolic dysfunctions.Results::This review discusses possible mechanisms linking gut microbiota dysbiosis and obesity, since there is a dual interaction between the two of them. Furthermore, comments on bariatric surgery, as a favourable model to understand the under…

medicine.medical_specialtyBariatric Surgery030209 endocrinology & metabolismGut floraManagement of obesity03 medical and health sciencesTherapeutic approach0302 clinical medicineDrug DiscoverymedicineAnimalsHumansMicrobiomeObesity030304 developmental biologyAdiposityPharmacologyInflammation0303 health sciencesbiologyHuman studiesbusiness.industryAnimalMicrobiotamedicine.diseasebiology.organism_classificationObesitySurgeryDysbiosiGastrointestinal MicrobiomeObesity-associated diseaseDysbiosisbusinessDysbiosisHumanCurrent pharmaceutical design
researchProduct

Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower …

2008

OBJECTIVE—Using the genome-wide association approach, we recently identified the glucokinase regulatory protein gene (GCKR, rs780094) region as a novel quantitative trait locus for plasma triglyceride concentration in Europeans. Here, we sought to study the association of GCKR variants with metabolic phenotypes, including measures of glucose homeostasis, to evaluate the GCKR locus in samples of non-European ancestry and to fine- map across the associated genomic interval. RESEARCH DESIGN AND METHODS—We performed association studies in 12 independent cohorts comprising >45,000 individuals representing several ancestral groups (whites from Northern and Southern Europe, whites from the …

AdultBlood GlucoseMaleLinkage disequilibriummedicine.medical_specialtyGenotypeEndocrinology Diabetes and MetabolismMutation Missense030209 endocrinology & metabolismLocus (genetics)Single-nucleotide polymorphismBiologyQuantitative trait locusPolymorphism Single Nucleotide03 medical and health sciences0302 clinical medicineGene FrequencyInternal medicineInternal MedicinemedicineGeneticsGlucose homeostasisHumansTriglycerides030304 developmental biologyGenetic associationAdaptor Proteins Signal TransducingAgedGenetics0303 health sciencesAnalysis of VarianceGlucokinase regulatory proteinGlucokinaseFastingMiddle AgedEndocrinologyC-Reactive Proteinbiology.proteinFemaleDiabetes
researchProduct

Emerging approaches for the treatment of hypertriglyceridemia.

2013

Hypertriglyceridemia is frequent in diabetic and obese subjects, who are at increased risk for cardiovascular diseases (CVD). Increased triglycerides (TG) are a hallmark of atherogenic dyslipidemia, representing a marker of atherogenic small dense low-density lipoproteins (sdlDL). Importantly, non-fasting/postprandial TG measurements tend to be emphasized in clinical practice for the prediction of CVD, and TG-lowering agents (primarily fibrates) have a beneficial effect on atherogenic dyslipidemia, reducing TG-rich particles and ultimately lowering the production of sdlDL. The combination of omega-3 fatty acids and statins is also recommended, and widely used in clinical practice for subjec…

PharmacologyHypertriglyceridemiamedicine.medical_specialtyAtherogenic dyslipidemiabusiness.industryHypertriglyceridemiaGeneral Medicinemedicine.diseaseBioinformaticsFish consumptionClinical PracticeEndocrinologyIncreased riskPostprandialInternal medicinecardiovascular diseases triglycerides hypertriglyceridemia triglyceride-lowering agentsmedicineIncreased triglyceridesHumansPharmacology (medical)Obese subjectsbusinessLife StyleHypolipidemic AgentsExpert opinion on pharmacotherapy
researchProduct

Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fast…

2008

Background: Hypertriglyceridemia is a risk factor for cardiovascular disease. Variation in the apolipoprotein A5 (APOA5) and glucokinase regulatory protein (GCKR) genes has been associated with fasting plasma triacylglycerol. Objective: We investigated the combined effects of the GCKR rs780094C→T, APOA5 −1131T→C, and APOA5 56C→G single nucleotide polymorphisms (SNPs) on fasting triacylglycerol in several independent populations and the response to a high-fat meal and fenofibrate interventions. Design: We used a cross-sectional design to investigate the association with fasting triacylglycerol in 8 populations from America, Asia, and Europe (n = 7730 men and women) and 2 intervention studies…

AdultMalemedicine.medical_specialtyGenotypeGene-Nutrient InteractionsMedicine (miscellaneous)Blood lipidsSingle-nucleotide polymorphismPolymorphism Single NucleotideYoung AdultFenofibrateGene FrequencyRisk FactorsInternal medicineHyperlipidemiamedicineHumansGenetic Predisposition to DiseaseApolipoproteins ATriglyceridesAdaptor Proteins Signal TransducingAgedHypolipidemic AgentsHypertriglyceridemiaNutrition and DieteticsFenofibrateGlucokinase regulatory proteinbiologyGlucokinaseHypertriglyceridemianutritional and metabolic diseasesGenetic VariationFastingMiddle Agedmedicine.diseasePostprandial PeriodDietary FatsPostprandialEndocrinologyCross-Sectional StudiesTreatment OutcomeApolipoprotein A-Vbiology.proteinlipids (amino acids peptides and proteins)Femalemedicine.drugThe American journal of clinical nutrition
researchProduct

Postprandial metabolism: from research to clinical practice.

2013

Over the last decade, the importance of postprandial metabolism has increased, given that it is the physiological state of humans in modern society. Moreover, postprandial lipemia is considered as a key player in the development of the most important cardiometabolic diseases. In this regard, postprandial lipemia has become more important, since it has been demonstrated that nonfasting triglycerides (TGs) are independent predictors of the risk of cardio vascular disease (CVD) [1,2]. Interestingly, the postprandial phase has been associated with increased inflammation and oxidation, which influences vascular function through a permanent endothelial aggression by atherogenic lipoprotein. TGs a…

medicine.medical_specialtyMediterranean dietbusiness.industryEndocrinology Diabetes and Metabolismdigestive oral and skin physiologycardiovascular disease lipoproteins Mediterranean diet metabolic syndrome postprandial lipemia triglyceridesInflammationMetabolismmedicine.diseaseClinical PracticeEndocrinologyPostprandialInternal medicinemedicinelipids (amino acids peptides and proteins)Metabolic syndromemedicine.symptomRisk factorCardiology and Cardiovascular MedicinebusinessChylomicron
researchProduct